Shares of Helixmith plunged Friday after the biotech firm announced that CanariaBio M will acquire the company.According to Helixmith on Thursday, the company agreed to transfer management rights to CanariaBio M, the parent company of CanariaBio. CanariaBio M has decided to pay 35 billion won ($27.2
On all counts, 2022 marked yet another memorable year for Korea’s bioindustry. Stories related to Covid-19 regarding quarantine and mask mandates garnered a lot of interest from our viewers as quarantine officials adopted a phased approach to relaxing mandates throughout the year.Of particular note
The Supreme Court, overturning existing precedents, has ruled that Oriental doctors can use diagnostic medical devices, such as ultrasound devices, causing repercussions.On Thursday, the Supreme Court overturned en banc the original ruling and acquitted an Oriental doctor charged with violating the
LegoChem Bioscience said it had transferred its antibody-drug conjugate (ADC) platform technology to Amgen in a deal worth 1.6 trillion won ($1.2 billion).Under the accord, Amgen will have the global development and commercialization rights for five targeted ADC therapies by utilizing its own antibo
Lawmakers said Thursday that health authorities may lift indoor mask mandates from next year, with further details scheduled to be announced on Friday.Government officials will announce the details of the mask-lifting mandate plans on Friday which will be conducted in a phased manner by mid-January.
The U.S. patent for Humira (ingredient: adalimumab), a representative blockbuster drug of AbbVie and the world's top-selling drug, will expire next year.As most of Humira's sales come from the U.S., industry watchers expect that competition in the U.S. adalimumab market will intensify as numerous ph
The government has recently shifted its system of selecting hospitals that can attract foreign patients from the designating system to the rating and certifying system while announcing criteria for imposing fines.Many domestic medical institutions gave a sigh of resignation due to such a change, com
Following Roche’s Tigagolumab, Gilead’s anti-TIGIT antibody candidate substance, Domvanalimab, has also shown consistent survival benefits when combined with anti-PD (programmed cell death)-(ligand) 1 antibody in phase 2 clinical trials.T-cell immunoreceptors with immunoglobulin and ITIM domains (TI
Digital healthcare, which was in the spotlight as the future of medical care and industry, is facing criticism that there is no output compared to input.However, those in the industrial field appeal that they are too tied up with various regulations, including data utilization, to produce results ev
Lunit, a Korean medical artificial intelligence (AI) solutions company, said on Thursday it signed a contract to supply AI breast cancer screening solutions to large hospitals in Hong Kong and Mongolia.Lunit will supply mammography AI image analysis solution, Lunit Insight MG, to Hong Kong's largest
Myongji Hospital on Thursday held an opening ceremony for its intervention center focused on conducting angiography, a type of X-ray to check blood vessels.The intervention center, which opened on the third floor of the hospital building D, gathered various angiography equipment, including the lates
Peptron said on Wednesday that it failed to secure statistical significance of the primary endpoint for its Parkinson’s disease treatment candidate (PT320) in phase 2a clinical trials but will continue developing the drug. Parkinson's patients at five hospitals including Seoul National University Ho
Uijeongbu St. Mary’s Hospital, one of the eight hospitals run by Catholic Medical Center, rejected 12 applicants citing “poor appearance” during its 2016 hiring process, an audit revealed.The Ministry of Education said Wednesday that it had found a total of 49 misconducts after conducting a comprehe
Dong-A ST said it has signed a joint research and technology transfer contract for a double fusion antibody immunotherapy developed by Kanaph Therapeutics.Under the agreement, Kanaph Therapeutics will receive an upfront fee of 5 billion won ($3.8 million). Dong-A ST will also provide up to 18 billio
Bioindustry analyst experts predicted that mergers and acquisitions (M&A) will play a central role next for the bioindustry at a seminar on bioindustry trends on Tuesday hosted by KoreaBIO, an association of local biotech firms.The seminar took a look at the global healthcare growth opportunities in
Quarantine officials said the proportion of Covid-19 patients who had previously tested positive has recently increased to about one in six newly confirmed daily cases.According to the Central Disease Control Headquarters (CDCH), there were 66,547 presumed reinfection cases out of 419,130 newly conf
A recent controversy over the appointment of the director of Kangbuk Samsung Hospital has led to a series of lawsuits.Professor Oh Tae-yoon of thoracic and cardiovascular surgery at the tertiary hospital said he applied for a provisional injunction with the Seoul Central District Court to suspend th
A local analyst said Hanmi Pharmaceutical's stock price will increase due to the earnings growth of Beijing Hanmi Pharmaceutical, backed by increased demand for cold medicine in China."Since China has been slowly changing into a With-Covid policy since December, the re-proliferation of Covid-19 is c
Handok and Novartis Korea signed a 2023 sales contract for three additional types of the latter's respiratory treatments in Korea.Handok was in charge of domestic sales of Onbrez in 2013, and with this contract, it will be in charge of distribution, sales, and promotion for three additional products
VUNO said on Wednesday that a multi-institutional study demonstrated the cardiac arrest predictive performance of VUNO Med-DeepCARS to monitor the risk of severe deterioration of pediatric inpatients when doctors and nurses were not around.Previous studies show that the number of cardiopulmonary res